Statins × cardiovascular events

TrialCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2012

The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial.

Victor Novack et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 17,802 people · 2012

Randomised comparison

Reduced cardiovascular events

−19%−33% to −3%

Bigger than 4 in 10 for cardiovascular events

As reported

HR 0.81, 95% CI 0.67–0.97

Range includes no effect

No clear effect on adverse events & safety

−17%−31% to +0%

Bigger than 5 in 10 for adverse events & safety

As reported

HR 0.83, 95% CI 0.69–1.00

Two numbers in the abstract

the abstract, start to end

in the placebo group (hazard ratio [HR] 0.83, 95% confidence interval [CI]

rosuvastatin and 250 given placebo (HR 0.81, 95% CI 0.67-0.97).

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
HR 0.830.69–1.00
Cardiovascular events
HR 0.810.67–0.97
StatinsCardiovascular eventsAdverse events & safety

Statins × cardiovascular eventshelps?replicated

unlikelylikely
0.860.85 without it

Statins × adverse events & safetyharms?mixed

unlikelylikely
0.160.16 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

37 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22431901